<SEC-DOCUMENT>0000899140-20-000390.txt : 20200901
<SEC-HEADER>0000899140-20-000390.hdr.sgml : 20200901
<ACCEPTANCE-DATETIME>20200901172856
ACCESSION NUMBER:		0000899140-20-000390
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20200901
DATE AS OF CHANGE:		20200901

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Entasis Therapeutics Holdings Inc.
		CENTRAL INDEX KEY:			0001724344
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				824592913
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-90651
		FILM NUMBER:		201155185

	BUSINESS ADDRESS:	
		STREET 1:		35 GATEHOUSE DRIVE
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
		BUSINESS PHONE:		(781) 810-0120

	MAIL ADDRESS:	
		STREET 1:		35 GATEHOUSE DRIVE
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Entasis Therapeutics Ltd
		DATE OF NAME CHANGE:	20171204

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Innoviva, Inc.
		CENTRAL INDEX KEY:			0001080014
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				943265960
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		2000 SIERRA POINT PARKWAY
		STREET 2:		SUITE 500
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
		BUSINESS PHONE:		6502389600

	MAIL ADDRESS:	
		STREET 1:		2000 SIERRA POINT PARKWAY
		STREET 2:		SUITE 500
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	THERAVANCE INC
		DATE OF NAME CHANGE:	20020207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADVANCED MEDICINE INC
		DATE OF NAME CHANGE:	20000302
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>i37127483.htm
<DESCRIPTION>SCHEDULE 13D/A (AMENDMENT NO. 3)
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: asdf
         Document created using EDGARfilings PROfile 7.0.1.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%-->
  <div>
    <div><br>
    </div>
    <div style="text-align: center; margin-right: 166.6pt; margin-left: 166.9pt; margin-top: 4.45pt; font-weight: bold;">UNITED STATES</div>
    <div style="text-align: center; margin-right: 166.6pt; margin-left: 167pt; margin-top: 0.5pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; margin-right: 166.45pt; margin-left: 167pt; margin-top: 2.05pt; font-weight: bold;">Washington, D.C.&#160; 20549</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="margin-top: 0.5pt;"><br>
    </div>
    <div style="text-align: center; margin-right: 166.6pt; margin-left: 166.95pt; font-size: 14pt; font-weight: bold;">SCHEDULE 13D/A</div>
    <div style="text-align: center; margin-right: 178.95pt; margin-left: 179.45pt; margin-top: 1.35pt; font-weight: bold;">Under the Securities Exchange Act of 1934 (Amendment No. 3)*</div>
    <div><br>
    </div>
    <div style="text-align: center; font-size: 14pt; font-weight: bold;">ENTASIS THERAPEUTICS HOLDINGS INC.</div>
    <div style="margin-top: 0.1pt;">
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="text-align: center; margin-right: 166.6pt; margin-left: 166.9pt; margin-top: 1.15pt;">(Name of Issuer)</div>
    <div style="margin-top: 1.15pt;"><br>
    </div>
    <div style="text-align: center; font-weight: bold;">Common Stock, $0.001 par value</div>
    <div style="margin-top: 0.1pt;">
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="text-align: center; margin-right: 166.55pt; margin-left: 167pt; margin-top: 1.15pt;">(Title of Class of Securities)</div>
    <div style="margin-top: 1.15pt;"><br>
    </div>
    <div style="text-align: center; font-weight: bold;">293614103</div>
    <div style="margin-top: 0.1pt;">
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="text-align: center; margin-right: 166.6pt; margin-left: 166.9pt; margin-top: 1.15pt;">(CUSIP Number)</div>
    <div style="margin-top: 1.15pt;"><br>
    </div>
    <div style="text-align: center; font-weight: bold;">Pavel Raifeld</div>
    <div style="text-align: center; font-weight: bold;">Chief Executive Officer</div>
    <div style="text-align: center; font-weight: bold;">Innoviva, Inc.</div>
    <div style="text-align: center; font-weight: bold;">1350 Old Bayshore Highway Suite 400</div>
    <div style="text-align: center; font-weight: bold;">Burlingame, CA</div>
    <div style="text-align: center; font-weight: bold;">877-202-1097</div>
    <div style="margin-top: 0.1pt;">
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="margin: 1.15pt 0px 0px; font-family: 'Times New Roman',Times,serif; text-align: center;">(Name, Address and Telephone Number of Person Authorized to </div>
    <div style="margin: 1.15pt 0px 0px; font-family: 'Times New Roman',Times,serif; text-align: center;">Receive Notices and Communications)</div>
    <div style="margin-top: 1.15pt;"><br>
    </div>
    <div style="text-align: center; font-weight: bold;">September 1, 2020</div>
    <div style="margin-top: 0.25pt;">
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="margin: 1.15pt 0px 0px; font-family: 'Times New Roman',Times,serif; text-align: center;">(Date of Event which Requires Filing of this Statement)</div>
    <div style="margin-top: 0.45pt;"><br>
    </div>
    <div style="text-align: justify; margin-right: 60.15pt; margin-left: 59pt;">If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of
      &#167;&#167;240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.&#160;&#160; &#9744;</div>
    <div style="margin-top: 0.45pt;"><br>
    </div>
    <div style="text-align: justify; margin-right: 60.2pt; margin-left: 59pt; margin-top: 4.55pt;"><font style="font-weight: bold;">Note</font>: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all
      exhibits. See &#167;240.13d-7 for other parties to whom copies are to be sent.</div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-right: 60.05pt; margin-left: 58.95pt; margin-top: 0.05pt;"><font style="font-size: 8pt;">* </font>The remainder of this cover page shall be filled out for a reporting person&#8217;s initial filing on this form with
      respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.</div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-right: 60.15pt; margin-left: 58.95pt; margin-top: 0.05pt;">The information required on the remainder of this cover page shall not be deemed to be &#8220;filed&#8221; for the purpose of Section 18 of the Securities Exchange
      Act of 1934 (&#8220;Act&#8221;) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).</div>
    <div style="margin-top: 0.45pt;"><br>
    </div>
    <div style="margin-right: 117.45pt; margin-left: 86pt; margin-top: 5.75pt; font-weight: bold;">Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB
      control number.</div>
    <div style="margin-top: 0.1pt;"><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">1</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    CUSIP No. 293614103
    <div style="margin: 3.7pt 0px 0px;">
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
    <font style="font-weight: bold;"></font>
    <div style="margin: 3.7pt 0px 0px;">
      <div>
        <table cellspacing="0" cellpadding="3" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 12pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <br>
              </td>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;</div>
              </td>
              <td colspan="5" style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt;">Names of Reporting Persons.<br>
                </div>
                <div style="font-size: 10pt;">I.R.S. Identification Nos. of above persons (entities only).<br>
                </div>
                <div>&#160;</div>
                <div style="margin-bottom: 1pt;">
                  <div style="font-size: 10pt;"><u>Innoviva, Inc.</u></div>
                </div>
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">2</font></div>
              </td>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt;">&#160;</div>
              </td>
              <td colspan="5" style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt;">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</div>
                <div style="margin-bottom: 1pt;"><font style="font-size: 10pt;">(a)&#160;&#160;<font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(b)&#160;&#160;<font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></font> <br>
                </div>
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">3</font></div>
              </td>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;</div>
              </td>
              <td colspan="5" style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt;">SEC USE ONLY</div>
                <div style="margin-bottom: 1pt;">&#160;</div>
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">4</font></div>
              </td>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;</div>
              </td>
              <td colspan="5" style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt;">SOURCE OF FUNDS</div>
                <div>&#160;</div>
                <div style="margin-bottom: 1pt;">WC</div>
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">5</font></div>
              </td>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;</div>
              </td>
              <td colspan="5" style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt;">CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)</div>
                <div>&#160;</div>
                <div style="margin-bottom: 1pt; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">6</font></div>
              </td>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;</div>
              </td>
              <td colspan="5" style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt;">CITIZENSHIP OR PLACE OF ORGANIZATION</div>
                <div>&#160;</div>
                <div style="margin-bottom: 1pt;">Delaware</div>
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td colspan="3" rowspan="4" style="width: 17.03%; vertical-align: middle; border-left: #000000 2px solid;">
                <div style="text-align: center; font-size: 10pt;">NUMBER&#160;OF</div>
                <div style="text-align: center; font-size: 10pt;">SHARES</div>
                <div style="text-align: center; font-size: 10pt;">BENEFICIALLY</div>
                <div style="text-align: center; font-size: 10pt;">OWNED&#160;BY</div>
                <div style="text-align: center; font-size: 10pt;">EACH</div>
                <div style="text-align: center; font-size: 10pt;">REPORTING</div>
                <div style="text-align: center; font-size: 10pt;">PERSON</div>
                <div style="text-align: center; font-size: 10pt;">WITH</div>
                <div style="margin-bottom: 1pt; font-size: 10pt;">&#160;</div>
                <div>&#160;</div>
              </td>
              <td style="width: 1.37%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;&#160;</div>
              </td>
              <td style="width: 2.76%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">7</font>&#160;</div>
              </td>
              <td style="width: 1.37%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;&#160;</div>
              </td>
              <td style="width: 77.48%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt;">SOLE VOTING POWER</div>
                <div>&#160;</div>
                <div style="margin-bottom: 1pt;">37,345,794 <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;&#160;</div>
              </td>
              <td style="width: 7.74%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">8</font></div>
              </td>
              <td style="width: 1.37%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;&#160;</div>
              </td>
              <td style="width: 2.76%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt;">SHARED VOTING POWER</div>
                <div>&#160;</div>
                <div style="margin-bottom: 1pt;">0<br>
                </div>
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;&#160;</div>
              </td>
              <td style="width: 7.74%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">9</font></div>
              </td>
              <td style="width: 1.37%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;&#160;</div>
              </td>
              <td style="width: 2.76%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt;">SOLE DISPOSITIVE POWER</div>
                <div>&#160;</div>
                <div style="margin-bottom: 1pt;">37,345,794 <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid;">
                <div>&#160;&#160;</div>
              </td>
              <td style="width: 7.74%; vertical-align: top;">
                <div style="font-size: 10pt; font-weight: bold; text-align: center;">10</div>
              </td>
              <td style="width: 1.37%; vertical-align: bottom; border-left: #000000 2px solid;">
                <div>&#160;&#160;</div>
              </td>
              <td style="width: 2.76%; vertical-align: top; border-right: #000000 2px solid;">
                <div style="font-size: 10pt;">SHARED DISPOSITIVE POWER</div>
                <div>&#160;</div>
                <div style="margin-bottom: 1pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">0</sup></div>
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; font-weight: bold; text-align: center;">11</div>
              </td>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;</div>
              </td>
              <td colspan="5" style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt;">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</div>
                <div>&#160;</div>
                <div style="margin-bottom: 1pt;">37,345,794 <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; font-weight: bold; text-align: center;">12</div>
              </td>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;</div>
              </td>
              <td colspan="5" style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt;">CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES</div>
                <div>&#160;</div>
                <div style="margin-bottom: 1pt; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; font-weight: bold; text-align: center;">13</div>
              </td>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;</div>
              </td>
              <td colspan="5" style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt;">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)</div>
                <div>&#160;</div>
                <div style="margin-bottom: 1pt;">69.0% <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><br>
                </div>
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; font-weight: bold; text-align: center;">14</div>
              </td>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;</div>
              </td>
              <td colspan="5" style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt;">TYPE OF REPORTING PERSON</div>
                <div>&#160;</div>
                <div>CO <br>
                </div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div> </div>
    <br>
    <div>
      <table cellspacing="0" cellpadding="0" id="zfe722122b3bd417ba8aa42e716312b11" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0.5pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="margin-left: 18pt; margin-top: 0.5pt;">(1)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="margin-top: 0.5pt;">
                <div>Based on 27,291,563 shares of Common Stock outstanding as of July 31, 2020, as reported by the Issuer in its Form 10-Q filed on August 6, 2020, <u>plus</u> (i) 8,183,878 shares of Common Stock issued by the Issuer on September 1,
                  2020, including 4,672,897 shares of Common Stock issued to the Reporting Person, (ii) warrants to purchase 14,000,000 shares of Common Stock acquired by the Reporting Person on June 11, 2020 and (iii) warrants to purchase 4,672,897 shares
                  of Common Stock acquired by the Reporting Person on September 1, 2020.</div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div> </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="margin-top: 0.2pt;">
      <div style="margin-left: 22.4pt; font-weight: bold;">Explanatory Note</div>
      <div style="margin-top: 0.4pt;"><br>
      </div>
      <div style="text-align: justify; margin-right: 23.65pt; margin-left: 36pt; margin-top: 0.05pt;">This Amendment No. 3 (the &#8220;<font style="font-style: italic;">Amendment No. 3</font>&#8221;) amends and supplements the initial Statement of Beneficial Ownership
        on Schedule 13D, as filed with the Securities and Exchange Commission on April 23, 2020, as amended by the amendment to Schedule 13D previously filed on June 11, 2020, as further amended by the amendment to Schedule 13D previously filed on August
        31, 2020 (as amended, the &#8220;<font style="font-style: italic;">Schedule 13D</font>&#8221;) with respect to shares of common stock, $0.001 par value per share (&#8220;<font style="font-style: italic;">Common Stock</font>&#8221;) of Entasis Therapeutics Holdings Inc., a
        Delaware corporation (the &#8220;<font style="font-style: italic;">Issuer</font>&#8221;) and warrants to acquire additional shares of Common Stock of the Issuer. Innoviva, Inc. (the &#8220;<font style="font-style: italic;">Reporting Person</font>&#8221;) is filing this
        amendment to reflect the acquisition of additional shares of Common Stock and Common Warrants (as defined below). Except as specifically amended and supplemented by this Amendment No. 3, the Schedule 13D remains in full force and effect.</div>
      <div style="margin-top: 0.25pt;"><br>
      </div>
      <div style="margin-left: 23.55pt; margin-top: 0.05pt; font-weight: bold;">Item 2. Identity and Background</div>
      <div style="margin-top: 0.05pt;"><br>
      </div>
      <div style="text-indent: 0.3pt; margin-left: 36pt; margin-top: 0.05pt;">Schedule I of Item 2 is amended and restated as set forth on Schedule I, attached hereto.</div>
      <div style="margin-top: 0.05pt;"><br>
      </div>
      <div style="margin-top: 0.05pt;"><br>
      </div>
      <div style="margin-left: 23.55pt; margin-top: 0.05pt; font-weight: bold;">Item 3. Source and Amount of Funds or Other Consideration</div>
      <div style="margin-left: 36pt; margin-top: 12pt; margin-bottom: 12pt;">Item 3 in Schedule 13D is hereby supplemented as follows:</div>
      <div style="text-indent: 0.3pt; margin-left: 36pt; margin-top: 0.05pt;">The aggregate purchase price for the Common Stock and the Common Warrants reported in this Amendment No.3 was approximately $12,500,000. The Common Stock and Warrants reported in
        this Amendment No.3 were acquired with funds provided from working capital of the Reporting Person.</div>
      <div style="margin-top: 0.05pt;"><br>
      </div>
      <div style="margin-left: 23.55pt; margin-top: 0.05pt; font-weight: bold;">Item 4. Purpose of Transaction</div>
      <div style="margin-left: 36pt; margin-top: 12pt; margin-bottom: 12pt;">Item 4 in Schedule 13D is hereby supplemented as follows:</div>
      <div style="margin-left: 36pt; margin-top: 12pt; margin-bottom: 12pt;">As previously disclosed on the Schedule 13D, on August 27, 2020, the Issuer entered into a securities purchase agreement (the &#8220;<font style="font-style: italic;">Securities
          Purchase Agreement</font>&#8221;) with the purchasers named therein (the &#8220;<font style="font-style: italic;">Investors</font>&#8221;), including the Reporting Person, pursuant to which the Issuer agreed to issue and sell (i) an aggregate of 8,183,878 shares
        of Common Stock (the &#8220;<font style="font-style: italic;">Shares</font>&#8221;), including 4,672,897 shares of Common Stock to be issued to the Reporting Person and (ii) warrants to purchase an aggregate of 10,507,710 shares of Common Stock (the &#8220;<font style="font-style: italic;">Common Warrants</font>&#8221;), including 4,672,897 Common Warrants to be issued to the Reporting Person.</div>
      <div style="margin-left: 36pt; margin-top: 12pt; margin-bottom: 12pt;">On September 1, 2020 in connection with the closing under the Securities Purchaser Agreement (the &#8220;<font style="font-style: italic;">Closing</font>&#8221;), the Issuer issued to the
        Reporting Person 4,672,897 Shares and Common Warrants to purchase 4,672,897 shares of Common Stock. Each Common Warrant issued to the Reporting Person is exercisable immediately and has a term of five years and an initial exercise price of $2.675.</div>
      <div style="margin-left: 36pt; margin-top: 12pt; margin-bottom: 12pt;">The Securities Purchase Agreement and the form of Common Warrant are attached as Exhibit 6 to the Schedule 13D of the Reporting Person filed with the U.S. Securities and Exchange
        Commission (the &#8220;<font style="font-style: italic;">SEC</font>&#8221;) on August 31, 2020 and are incorporated by reference in this Amendment No. 3; any description herein of the Securities Purchase Agreement and the form of Common Warrant are qualified
        in their entirety by reference to the Securities Purchase Agreement and form of Common Warrant so filed by the Reporting Person.</div>
      <div style="margin-left: 36pt; margin-top: 12pt; margin-bottom: 12pt;">The Reporting Person may, from time to time and at any time, either alone or together with others: (i) acquire additional Common Stock and warrants and/or other equity, debt,
        notes, instruments or other securities (collectively, &#8220;<font style="font-style: italic;">Securities</font>&#8221;) of the Issuer in the open market or otherwise&#894; (ii) dispose of any or all of its Securities in the open market or otherwise&#894; or (iii)
        engage in any hedging or similar transactions with respect to the Securities. The Reporting Person purchased the Common Stock and Common Warrants reported in this Amendment No. 3 for investment purposes.</div>
    </div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div> <br>
    </div>
    <div>
      <div><br>
      </div>
      <div style="margin-left: 23.55pt; margin-top: 0.05pt; font-weight: bold;">Item 5. Interest in Securities of the Issuer</div>
      <div style="margin-left: 36pt; margin-top: 12pt; margin-bottom: 12pt;">Item 5 in Schedule 13D is hereby amended and restated as follows:</div>
      <div style="text-indent: 36pt;">The information contained in the cover page and in Item 4 to this Schedule 13D is hereby incorporated by reference</div>
      <div style="text-indent: 36pt;">into this Item 5. The Reporting Person did not otherwise acquire or sell any shares of Common Stock or other securities </div>
      <div style="margin-left: 36pt; margin-top: 0.5pt;">of the Issuer during the last 60 days.</div>
      <div style="margin-top: 0.5pt;"><br>
      </div>
      <div style="text-indent: 36pt; margin-top: 0.05pt; font-weight: bold;">Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer</div>
      <div style="margin-top: 0.4pt;"><br>
      </div>
      <div style="margin-left: 36pt;">Item 6 in Schedule 13D is hereby supplemented as follows:</div>
      <div><br>
      </div>
      <div style="margin-left: 36pt;">The information contained above in Item 4 is hereby incorporated by reference into this Item 6.</div>
      <div><br>
      </div>
      <div style="margin-left: 36pt;">In connection with the Securities Purchase Agreement, at the Closing the Issuer entered into a Registration Rights Agreement (the &#8220;<font style="font-style: italic;">Registration Rights Agreement</font>&#8221;) with the
        Investors. Pursuant to the Registration Rights Agreement, the Issuer agreed to prepare and file a registration statement with the SEC within 45 days after the closing for purposes of registering the resale of the Shares, the shares of Common Stock
        issuable upon exercise of the Common Warrants, the Common Warrants and any shares of Common Stock issued as a dividend or other distribution with respect to the Shares or shares of Common Stock issuable upon exercise of the Common Warrants. The
        Issuer also agreed to use its reasonable best efforts to cause this registration statement to be declared effective by the SEC within 90 days after the closing of the Offering (or within 120 days if the SEC reviews the registration statement).</div>
      <div><br>
      </div>
      <div style="margin-left: 36pt;">The Registration Rights Agreement is attached as Exhibit 10.2 to the Form 8-K of the Issuer filed with the SEC on September 1, 2020 and is incorporated by reference in this Schedule 13D; any description herein of the
        Registration Rights Agreement is qualified in its entirety by reference to the Registration Rights Agreement so filed by the Issuer.</div>
      <div><br>
      </div>
      <div style="margin-left: 23pt; margin-top: 3.15pt; font-weight: bold;">Item 7. Material to Be Filed as Exhibits</div>
      <div style="margin-left: 36pt; margin-top: 12pt;">Exhibit 7 &#8211; Securities Purchase Agreement, dated as of August 27, 2020, by and among Entasis Therapeutics Holdings Inc. and the Investors named therein, including certain exhibits thereto
        (incorporated by reference to Exhibit 6 to the Schedule 13D of the Issuer filed with the SEC on August 31, 2020).</div>
      <div style="margin-left: 36pt; margin-bottom: 12pt;">Exhibit 8 &#8211; Registration Rights Agreement, dated September 1, 2020, by and between the Company and the Investors named therein (incorporated by reference to Exhibit 1.2 to the Form 8-K of the
        Issuer filed with the SEC on September 1, 2020).</div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <br>
    <div><br>
    </div>
    <div style="text-align: center; margin-left: 23pt; font-weight: bold;">SIGNATURE</div>
    <div style="margin-top: 0.45pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 23.6pt; margin-left: 23pt;">After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 23.6pt; margin-left: 23pt;">Dated: September 1, 2020</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; margin-right: 23.6pt; margin-left: 23pt;"><font style="font-weight: bold;">INNOVIVA, INC.<br>
      </font><br>
    </div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; margin-right: 23.6pt; margin-left: 23pt; font-weight: bold;">By: <u>/s/ Pavel Raifeld&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
      </u></div>
    <div style="margin-right: 23.6pt; margin-left: 36pt; font-weight: bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name: Pavel Raifeld</div>
    <div style="margin-right: 23.6pt; margin-left: 36pt; font-weight: bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title: Chief Executive Officer</div>
    <div><br>
    </div>
    <div> <br>
    </div>
    <div> <br>
    </div>
    <div> <br>
    </div>
    <div> <br>
    </div>
    <div> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <div><br>
      </div>
      <div style="background-color: #FFFFFF;">
        <div style="text-align: center; font-weight: bold;">SCHEDULE I</div>
      </div>
      <div style="background-color: #FFFFFF;">
        <div><br>
        </div>
        <div>The following information is set forth below with respect to each executive officer and director of the Reporting Person: name, business address, position with the Reporting Person and present principal occupation or employment and, for
          persons not employed by the Reporting Persons, the name, principal business and address of any corporation or other organization in which such employment is conducted.</div>
        <div><br>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zf141997861e34929aad233e195101b74">

          <tr>
            <td style="width: 18.59%; vertical-align: top; background-color: #FFFFFF; border-bottom: #000000 2px solid;">
              <div style="font-weight: bold;">Name</div>
            </td>
            <td style="width: 14.1%; vertical-align: top; background-color: #FFFFFF; border-bottom: #000000 2px solid;">
              <div style="font-weight: bold;">Business Address</div>
            </td>
            <td style="width: 25.97%; vertical-align: top; background-color: #FFFFFF; border-bottom: #000000 2px solid;">
              <div style="font-weight: bold;">Position with Reporting Person</div>
            </td>
            <td style="width: 25.53%; vertical-align: top; background-color: #FFFFFF; border-bottom: #000000 2px solid;">
              <div style="margin-right: 7.5pt; font-weight: bold;">Present Principal Occupation or Employment</div>
            </td>
            <td style="width: 15.8%; vertical-align: top; background-color: #FFFFFF; border-bottom: #000000 2px solid;">
              <div style="font-weight: bold;">Citizenship</div>
            </td>
          </tr>
          <tr>
            <td style="width: 18.59%; vertical-align: top; background-color: #FFFFFF; border-bottom: 2px solid black;">
              <div style="font-weight: bold;">Directors</div>
            </td>
            <td style="width: 14.1%; vertical-align: top; background-color: #FFFFFF;">
              <div style="font-size: 12pt;">&#160;</div>
            </td>
            <td style="width: 25.97%; vertical-align: top; background-color: #FFFFFF;">
              <div style="font-size: 12pt;">&#160;</div>
            </td>
            <td style="width: 25.53%; vertical-align: top; background-color: #FFFFFF;">
              <div style="margin-right: 7.5pt; font-size: 12pt;">&#160;</div>
            </td>
            <td style="width: 15.8%; vertical-align: top; background-color: #FFFFFF;">
              <div style="font-size: 12pt;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 18.59%; vertical-align: top; background-color: #FFFFFF;">
              <div>George W. Bickerstaff, III</div>
            </td>
            <td style="width: 14.1%; vertical-align: top; background-color: #FFFFFF;">
              <div>(1)</div>
            </td>
            <td style="width: 25.97%; vertical-align: top; background-color: #FFFFFF;">
              <div>Director</div>
            </td>
            <td style="width: 25.53%; vertical-align: top; background-color: #FFFFFF;">
              <div style="margin-right: 7.5pt;">Managing Director of M.M. Dillon &amp; Co., LLC (2)</div>
            </td>
            <td style="width: 15.8%; vertical-align: top; background-color: #FFFFFF;">
              <div>United States</div>
            </td>
          </tr>
          <tr>
            <td style="width: 18.59%; vertical-align: top; background-color: #FFFFFF;">
              <div>Mark DiPaolo</div>
            </td>
            <td style="width: 14.1%; vertical-align: top; background-color: #FFFFFF;">
              <div>(1)</div>
            </td>
            <td style="width: 25.97%; vertical-align: top; background-color: #FFFFFF;">
              <div>Director</div>
            </td>
            <td style="width: 25.53%; vertical-align: top; background-color: #FFFFFF;">
              <div style="margin-right: 7.5pt;">Partner and the General Counsel of Sarissa Capital Management LP (3)</div>
            </td>
            <td style="width: 15.8%; vertical-align: top; background-color: #FFFFFF;">
              <div>United States</div>
            </td>
          </tr>
          <tr>
            <td style="width: 18.59%; vertical-align: top; background-color: #FFFFFF;">
              <div>Jules Haimovitz</div>
            </td>
            <td style="width: 14.1%; vertical-align: top; background-color: #FFFFFF;">
              <div>(1)</div>
            </td>
            <td style="width: 25.97%; vertical-align: top; background-color: #FFFFFF;">
              <div>Director</div>
            </td>
            <td style="width: 25.53%; vertical-align: top; background-color: #FFFFFF;">
              <div style="margin-right: 7.5pt;">President of Haimovitz Consulting, Inc. (4)</div>
            </td>
            <td style="width: 15.8%; vertical-align: top; background-color: #FFFFFF;">
              <div>United States</div>
            </td>
          </tr>
          <tr>
            <td style="width: 18.59%; vertical-align: top; background-color: #FFFFFF;">
              <div>Odysseas D. Kostas</div>
            </td>
            <td style="width: 14.1%; vertical-align: top; background-color: #FFFFFF;">
              <div>(1)</div>
            </td>
            <td style="width: 25.97%; vertical-align: top; background-color: #FFFFFF;">
              <div>Director</div>
            </td>
            <td style="width: 25.53%; vertical-align: top; background-color: #FFFFFF;">
              <div style="margin-right: 7.5pt;">Partner and Senior Analyst at Sarissa Capital Management LP (3)</div>
            </td>
            <td style="width: 15.8%; vertical-align: top; background-color: #FFFFFF;">
              <div>United States</div>
            </td>
          </tr>
          <tr>
            <td style="width: 18.59%; vertical-align: top; background-color: #FFFFFF;">
              <div>Sarah Schlesinger</div>
            </td>
            <td style="width: 14.1%; vertical-align: top; background-color: #FFFFFF;">
              <div>(1)</div>
            </td>
            <td style="width: 25.97%; vertical-align: top; background-color: #FFFFFF;">
              <div>Director</div>
            </td>
            <td style="width: 25.53%; vertical-align: top; background-color: #FFFFFF;">
              <div style="margin-right: 7.5pt;">Associate Professor of Clinical Investigation at Rockefeller</div>
              <div style="margin-right: 7.5pt;">University and Senior Attending Physician at Rockefeller University Hospital (5)</div>
            </td>
            <td style="width: 15.8%; vertical-align: top; background-color: #FFFFFF;">
              <div>United States</div>
            </td>
          </tr>
          <tr>
            <td style="width: 18.59%; vertical-align: top; background-color: #FFFFFF;">
              <div style="font-size: 12pt;">&#160;</div>
            </td>
            <td style="width: 14.1%; vertical-align: top; background-color: #FFFFFF;">
              <div style="font-size: 12pt;">&#160;</div>
            </td>
            <td style="width: 25.97%; vertical-align: top; background-color: #FFFFFF;">
              <div style="font-size: 12pt;">&#160;</div>
            </td>
            <td style="width: 25.53%; vertical-align: top; background-color: #FFFFFF;">
              <div style="margin-right: 7.5pt; font-size: 12pt;">&#160;</div>
            </td>
            <td style="width: 15.8%; vertical-align: top; background-color: #FFFFFF;">
              <div style="font-size: 12pt;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 18.59%; vertical-align: top; background-color: #FFFFFF; border-bottom: 2px solid black;">
              <div style="font-weight: bold;">Executive Officers</div>
            </td>
            <td style="width: 14.1%; vertical-align: top; background-color: #FFFFFF;">
              <div style="font-size: 12pt;">&#160;</div>
            </td>
            <td style="width: 25.97%; vertical-align: top; background-color: #FFFFFF;">
              <div style="font-size: 12pt;">&#160;</div>
            </td>
            <td style="width: 25.53%; vertical-align: top; background-color: #FFFFFF;">
              <div style="margin-right: 7.5pt; font-size: 12pt;">&#160;</div>
            </td>
            <td style="width: 15.8%; vertical-align: top; background-color: #FFFFFF;">
              <div style="font-size: 12pt;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 18.59%; vertical-align: top; background-color: #FFFFFF;">
              <div>Pavel Raifeld</div>
            </td>
            <td style="width: 14.1%; vertical-align: top; background-color: #FFFFFF;">
              <div>(1)</div>
            </td>
            <td style="width: 25.97%; vertical-align: top; background-color: #FFFFFF;">
              <div>Chief Executive Officer</div>
            </td>
            <td style="width: 25.53%; vertical-align: top; background-color: #FFFFFF;">
              <div style="margin-right: 7.5pt;">Chief Executive Officer of the Reporting Person</div>
            </td>
            <td style="width: 15.8%; vertical-align: top; background-color: #FFFFFF;">
              <div>United States</div>
            </td>
          </tr>
          <tr>
            <td style="width: 18.59%; vertical-align: top; background-color: #FFFFFF;">
              <div>Marianne Zhen</div>
            </td>
            <td style="width: 14.1%; vertical-align: top; background-color: #FFFFFF;">
              <div>(1)</div>
            </td>
            <td style="width: 25.97%; vertical-align: top; background-color: #FFFFFF;">
              <div>Chief Accounting Officer</div>
            </td>
            <td style="width: 25.53%; vertical-align: top; background-color: #FFFFFF;">
              <div style="margin-right: 7.5pt;">Chief Accounting Officer of the Reporting Person</div>
            </td>
            <td style="width: 15.8%; vertical-align: top; background-color: #FFFFFF;">
              <div>United States</div>
            </td>
          </tr>

      </table>
      <div style="background-color: #FFFFFF;">
        <div><br>
        </div>
        <div>(1) 1350 Old Bayshore Highway Suite 400, Burlingame, CA.</div>
        <div>(2) M.M. Dillon &amp; Co., LLC is an investment banking firm. The address of M.M. Dillon &amp; Co., LLC is 1 Sound Shore Dr, Greenwich, CT 06830.</div>
        <div>(3) Sarissa Capital Management LP is a registered investment advisor. The address of Sarissa Capital Management LP is 660 Steamboat Rd, Greenwich, CT 06830.</div>
        <div>(4) Haimovitz Consulting Inc. is a consulting firm. The address of Haimovitz Consulting, Inc. is N/A.</div>
        <div>(5) Rockefeller University and the Rockefeller University Hospital are a center for research and graduate education in the biomedical sciences, chemistry, bioinformatics and physics. The address of Rockefeller University and Rockefeller
          University Hospital is 1230 York Ave, New York, NY 10065.</div>
      </div>
      <div><br>
      </div>
    </div>
  </div>
  <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
